Riverside Brings Research and Cancer Clinical Trials Right to Our Communities

“Connect” The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)

The purpose of the Connect® MDS/AML Disease Registry is to provide unique insights into treatment regimens and sequencing of these regimens as they relate to clinical outcomes of patients with newly diagnosed Myelodysplastic Syndrome (MDS), Idiopathic Cytopenia of Undetermined Significance (ICUS) or Acute Myeloid Leukemia (AML) in routine clinical practice and evaluate molecular and cellular markers that may provide further prognostic classification and/or might be predictive of therapy outcomes.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Prospective Survey and Registry Study of Financial Toxicity in Cancer Patients Undergoing Radiotherapy in a Regional Cancer Center

All cancer types

The goal of this research study is to learn about the prevalence of financial toxicity in cancer patients undergoing radiotherapy in a community cancer center and investigate which factors are associated with harmful effects of high cost of treatment. Financial toxicity is defined as the harmful effects of the high cost of cancer treatment on a person’s qualify of life.

COMPASS-HER2 _A011801: The COMPASSHER2 Residual Disease Trial A Double-Blinded, Phase III Randomized Trial of T-DM1 Compared with T-DM1 and Tucatinib

Breast Cancer

This study is being done to answer the following question: Is the combination of T-DM1 and a newer drug tucatinib, better than usual treatment with T-DM1 alone in preventing breast cancer from returning? We are doing this study because we want to find out if this approach is better or worse than the usual approach for breast cancer.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.)

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

Triple Negative Breast Cancer Riverside Observational Study 012013 - An observational study of triple negative breast cancer at a Community Hospital

Breast Cancer

The goal of this study is to collect information on how patients who have triple negative breast cancer present with the illness, and how they respond to the treatments they receive. There will be no changes to the treatment you will receive from your doctor. This study will not require you to undergo any specific treatment, tests or evaluations. Information regarding the history of your breast cancer, results of tests and treatments done will be collected from your medical record by the research staff. Twice a year for the duration of the study, updated information concerning your status and any intervening treatments will be collected.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Prospective Survey and Registry Study of Financial Toxicity in Cancer Patients Undergoing Radiotherapy in a Regional Cancer Center

All cancer types

The goal of this research study is to learn about the prevalence of financial toxicity in cancer patients undergoing radiotherapy in a community cancer center and investigate which factors are associated with harmful effects of high cost of treatment. Financial toxicity is defined as the harmful effects of the high cost of cancer treatment on a person’s qualify of life.

Anal Cancer Study- EA2176: A Randomized Phase III Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Naïve Metastatic Anal Cancer Patients .

Colorectal Cancer

The purpose of the EA2176 study is to compare chemotherapy alone (this is the standard treatment for metastatic anal cancer) to chemotherapy plus immunotherapy (nivolumab). Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. This study will help the study doctors find out if chemotherapy plus immunotherapy helps reduce symptoms and stop your cancer from growing.

Colorectal Cancer

For patients with colorectal cancer undergoing surgery regardless of the stage of disease, this circulating tumor DNA biomarker may potentially identify patients who would benefit the most from systemic adjuvant (additional) treatment, even in the absence of other clinical features traditionally considered high-risk. However, use of circulating tumor DNA technology is limited by the absence of prospective data for demonstrating benefit as a predictive biomarker for adjuvant chemotherapy.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.)

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Prospective Survey and Registry Study of Financial Toxicity in Cancer Patients Undergoing Radiotherapy in a Regional Cancer Center

All cancer types

The goal of this research study is to learn about the prevalence of financial toxicity in cancer patients undergoing radiotherapy in a community cancer center and investigate which factors are associated with harmful effects of high cost of treatment. Financial toxicity is defined as the harmful effects of the high cost of cancer treatment on a person’s qualify of life.

OVERT Ovarian Cancer Clinical trial _AOA Dx: non-invasive blood test to assess the likelihood of ovarian malignancy

Ovarian Cancer

An ovarian cancer research trial to evaluate the effectiveness of a new blood test for the early detection of ovarian cancer. AOA Dx has identified a selection of blood markers that have been linked to Ovarian Cancer. By collecting the blood of women with signs and symptoms of ovarian cancer, AOA Dx can evaluate the accuracy of the markers for the early detection of the disease.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Prospective Survey and Registry Study of Financial Toxicity in Cancer Patients Undergoing Radiotherapy in a Regional Cancer Center

All cancer types

The goal of this research study is to learn about the prevalence of financial toxicity in cancer patients undergoing radiotherapy in a community cancer center and investigate which factors are associated with harmful effects of high cost of treatment. Financial toxicity is defined as the harmful effects of the high cost of cancer treatment on a person’s qualify of life.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients. 

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Prospective Survey and Registry Study of Financial Toxicity in Cancer Patients Undergoing Radiotherapy in a Regional Cancer Center

All cancer types

The goal of this research study is to learn about the prevalence of financial toxicity in cancer patients undergoing radiotherapy in a community cancer center and investigate which factors are associated with harmful effects of high cost of treatment. Financial toxicity is defined as the harmful effects of the high cost of cancer treatment on a person’s qualify of life.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Prospective Survey and Registry Study of Financial Toxicity in Cancer Patients Undergoing Radiotherapy in a Regional Cancer Center

All cancer types

The goal of this research study is to learn about the prevalence of financial toxicity in cancer patients undergoing radiotherapy in a community cancer center and investigate which factors are associated with harmful effects of high cost of treatment. Financial toxicity is defined as the harmful effects of the high cost of cancer treatment on a person’s qualify of life.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Oral Chemo Perceptions Study Riverside 012016 - A survey and Registry Study of Patient Perceptions and Experiences with Oral Chemotherapy at a Community Hospital

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma.

The goal of this study is to collect information on how patients perceive the experience of being treated with oral chemotherapy. Patients enrolled to this study will have a cancer diagnosis and are currently being treated with oral chemotherapy (which started 3-6 months prior to participation.) 

Breast Cancer, Colon-Rectal Cancer, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Non-Small-Cell Lung Cancer, Melanoma, or Myeloma

The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.

IMPACTS PAIN management tool for Cancer Survivors_WF-1901: Internet-delivered management of Pain Among Cancer Treatment Survivors (IMPACTS)

Do you experience physical or emotional pain related to your cancer or cancer treatment ? The IMPACTS Study "Internet-delivered Management of Pain Among Cancer Treatment Survivors", is designed to help you manage your pain so you can enjoy your quality of life. Cancer patients 18 or older who experience pain from cancer or cancer related treatment are invited to discuss possible participation in the IMPACTS study.

Cancer Health Care Disparities Tool - DCP-001: Use of a Clinical Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)

All cancer types

The purpose of this project is to understand who participates in clinical trials and for those who do not participate, the reasons why. This information will help researchers design future studies. Also, to address the reasons people do not participate, especially young adults and teenagers, older people and minorities. In addition, personal and medical information will be collected to help understand differences in treatment and treatment outcomes among these populations. The data collected will be used by: 1. NCI to evaluate the overall performance of the community program (NCORP) 2. The medical team to better understand reasons patients don’t participate, especially reasons related to the institution or the clinical trial 3. Researchers to improve the design of current and future studies 4. Researchers to develop research questions such as differences in access to care, treatment received and the outcome of the treatment received by different populations.

Meagan Gualtiere, BSN, RN

Clinical Research Coordinator

Research coordinators are primarily responsible for study coordination and data management, with specialty focus on managing the care of research participants. In addition to providing coordinating clinical care, research coordinators have a central role in assuring participant safety, ongoing maintenance of study activities, integrity of protocol and accuracy of data collection and information recording and follow up.

Katie Blomgren, RN, CRC

Clinical Research Coordinator

Research coordinators are primarily responsible for study coordination and data management, with specialty focus on managing the care of research participants. In addition to providing coordinating clinical care, research coordinators have a central role in assuring participant safety, ongoing maintenance of study activities, integrity of protocol and accuracy of data collection and information recording and follow up.

Casey Morris, BA

Research Regulatory Coordinator

Supports clinical research team by facilitating the protocol approval process, maintaining regulatory information, and ensuring compliance with regulatory affairs, coordinating study related activities and maintaining research policies and procedures.